Dexedrine¿ (dextroamphetamine) Spansules¿ recalls
The FDA has published 1 recall involving Dexedrine¿ (dextroamphetamine) Spansules¿ since 2014. The latest was reported on 1 Jan 2014. Most were for potency & assay. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls1since 2014
Last 12 months0reported
Class I00% of total
Ongoing0latest 1 Jan 2014
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 100%Class III 0 0%
Why dexedrine¿ (dextroamphetamine) spansules¿ is recalled
Companies
By year
All dexedrine¿ (dextroamphetamine) spansules¿ recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Dexedrine¿ (Dextroamphetamine Sulfate) Spansules¿ recalled | Amedra Pharmaceuticals | Potency & Assay | Nationwide |
Should you stop taking Dexedrine¿ (dextroamphetamine) Spansules¿?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.